Working Groups

Latest News

Register now

ISAC is proud to support the upcoming 4th International Conference on Polymyxins.

Read More
Travel Grants to attend ...

Apply for Young Investigator &Eastern Europe Travel Grants for Istanbul.

Read More

Membership

Current Officers

F Wagenlehner

Chairperson

Florian Wagenlehner

L Nicolle

Vice-Chair

Lindsay E. Nicolle

Secretary

Shingo Yamamoto

Treasurer

Seung-Ju Lee

All Members

Soichi Arakawa (Japan)
Truls E. Bjerklund Johansen (Denmark)
Yong-Hyun Cho (Korea)
Reinhard Fünfstück (Germany)
Suzanne Geerlings (The Netherlands)
Kalpana Gupta (USA)
Jorge Milhem Haddad (Brazil)
Thomas M. Hooton (USA)
Chul-Sung Kim, Gwangju (Korea)
John N. Krieger (USA)
Hiromi Kumon (Japan)
Seung-Ju Lee (Korea)
Gabriel Levy Hara (Argentina)
Raul Raz (Israel)
Anthony J. Schaeffer (USA)
Sourabh Sharma (India)
Stephen Shei-Dei Yang (Taiwan)
Lu-Dong Qiao (China)
Shingo Yamamoto (Japan)


Honorary Members

Sadao Kamidono (Japan)
Yukimiti Kawada ( Japan)
Yoshiaki Kumamoto (Japan)
Jyoichi Kumazawa (Japan)
Allan R. Ronald (Canada)
Kurt G. Naber (Germany)

 

 

How to Join

ISAC Working Groups are open to new members with a strong interest and relevant experience in the given field. To join an ISAC Working Group, please contact Fee Johnstone, ISAC Executive Officer secretariat@isac.world with your name and a brief C.V. We welcome new members!

Aims and Objectives

History
On the 10th anniversary of the Japanese UTI Committee, its chairman (Professor Masaaki Ohkoshi) invited interested colleagues from North America and Europe to the 1st International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection, in October 1989 in Tokyo, Japan. The international commission for UTI was founded, which later became affiliated to the International Society of Antimicrobial Chemotherapy. It was decided to organize an International Symposium on Clinical Evaluation of Drug Efficacy in Urinary Tract Infection biannually, in connection with the International Congress of Chemotherapy.


International Symposia on Clinical Evaluation of Drug Efficacy in UTI
The aims of these meetings are to discuss the various aspects of UTI on a broad international base, to achieve a widely accepted consensus concerning management and clinical studies and to come to a growing bibliography on this subject, which could be useful for the daily clinical decisions to be made.

Presentations

November 2020

Uncomplicated UTI summit



2020

KAUTI meeting cancelled due to COVID-19

 November 2019

KAUTII Expert meeting Je-Ju Island Korea, Symposium

Paradigm shift to Urinary Tract Infection Management 좌장: 김영호 (순천향의대)
Roles of immunotherapy in multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome using UPOINT 이승주 (가톨릭의대) Seung-Ju Lee

Recent management of chronic prostatitis / chronic pelvic pain syndrome using UPOINT Florian Wagenlehner (Department of Urology Justus-Liebig-University Giessen, Germany)
Discussion : proper patient characteristics for immunotherapy 정승일 (전남의대), 최현섭 (가톨릭의대), 최훈 (고려의대), 임동훈 (조선의대), 김광택 (가천의대)

Luncheon Symposium Young Ho Kim (Soonchunhyang University, Korea)
Roles of immunotherapy in uncomplicated recurrent cystitis Florian Wagenlehner (Department of Urology Justus-Liebig-University Giessen, Germany) 

September 2019

UTI Working Group symposium at SEEC, Montenegro

Session 5: International Society of Antimicrobial Chemotherapy
Chairpersons: Kurt Naber, Sabina Mahmutovic-Vranic, Deyan Anakievski
Targeted prophylaxis for prostate biopsy - predicting factors of infectious
Complications Orlin Savov Germany
Modeling The Impact of Self-Collected versus Clinician-Collected Testing in STDs Diagnostics Sabina Mahmutovic-Vranic Sarajevo, Bosnia and Herzegovina
Novel antibiotics in complicated UTI Kurt Naber Germany

October 2018

9th SEEC conference in Sarajevo October

Session 5: International Society of Antimicrobial Chemotherapy
Chairpersons: Kurt Naber, Sabina Mahmutovic-Vranic, Deyan Anakievski
Targeted prophylaxis for prostate biopsy - predicting factors of infectious
Complications Orlin Savov Germany
Modeling The Impact of Self-Collected versus Clinician-Collected Testing in STDs Diagnostics Sabina Mahmutovic-Vranic Sarajevo, Bosnia and Herzegovina
Novel antibiotics in complicated UTI: Kurt Naber Germany

November 2016 Symposium at 6th SEEC, Thessaloniki, Greece
March 2015 Symposium at the European Association of Urology, Madrid
June 2013 Symposium at the 28th ICC, Yokohama, Japan
November 2012 Symposium at the 3rd SEEC, Dubrovnik, Croatia
October 2012 Symposium at the 13th APCCMI, Beijing, China
November 2011 Symposium at the 2nd SEEC, Belgrade, Serbia
June 2011 Symposium at 59th Annual Meeting JSC, Sapporo, Japan
May 2011 21st ECCMID / 27th ICC, Milan, Italy
May 2010 1st SEEC, Varna, Bulgaria

Projects / Publications

The Masaaki Ohkoshi Award
The award was founded in 1995 for the best clinical study on the subject of urinary tract infections published during a two-year period. The first three awards were sponsored by Professor Masaaki Ohkoshi and all subsequent awards have been sponsored by the Japanese UTI Committee. These awards have been presented at every International Congress of Chemotherapy since 1995 and the most recent recipient awardees were Ildikó Gagyor and Jutta Bleidorn from Germany who were presented in Taiwan, 2017.

Please click HERE for more information.  


2010 Publication

International Consultation on Urogenital Infections. Naber KG, Schaeffer AJ, Heyns C, Matsumoto T, Shoskes DA, Bjerklund Johansen TE. First edition 2010. European Association of Urology.  

The international consultation on urogenital infections was a joint consultation initiated by the International Consultation on Urological Diseases (ICUD), the European Association of Urology (EAU), the Asian Association of UTI/STD, the Society of Infection and Inflammation in Urology (SIIU) and the UTI commission of the International Society of Chemotherapy for Infection and Cancer (ISC).  This international consultation on urogential infections will be updated in 2016 in the form of a living textbook.

 

2008 Publication

European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. P. Tenke, B. Kovacs, T.E. Bjerklund, Johansen, T. Matsumoto, P.A. Tambyah, K.G. Naber. International Journal of Antimicrobial Agents (2008) S68 – S78.

The ISAC Working Group on UTI collaborated with the following bodies to publish the guidelines detailed above:European Association of UrologyEuropean Society for Infections in UrologyUrological Association of AsiaAsian Association of UTI / STD Western Pacific Society for ChemotherapyFederation of European Societies for Chemotherapy and Infection


UTI Commission Symposia

The proceedings of the UTI Commission Symposia have been published as either a separate booklet or, more often, as a supplement to a scientific journal. The intention of these publications is to discuss the various aspects of UTI on a broad international base, to achieve a widely accepted consensus concerning management and clinical studies and to come to a growing bibliography on this subject, which could be useful for daily clinical decisions.

The following symposia have been published in the International Journal of Antimicrobial Agents and are freely available HERE

Volume 38, Supplement 1, pages 1-70 (December 2011)
Volume 31, Supplement 1, pages 1-116 (February 2008)
Volume 28, Supplement 1, pages 1-112 (August 2006)
Volume 24, Supplement 1, pages 1-75 (September 2004)
Volume 23, Supplement 1, pages 1-87 (March 2004)
Volume 22, Supplement 2, pages 27-100 (October 2003)

Future / Ongoing Activities

• All members included in several national and international guidelines in management of different types of UTI: American guidelines, European guidelines, Asian guidelines. One aim is to homogenize the guidelines and focus on the differences and common aspects of the guidelines.

• We do have studies such as registry studies, that are performed in different aspects of UTI (such as the GPIU study, etc.). We want to extend these studies further.

• We would like to extend our network of researchers engaged in urogenital infections, to serve as a platform where interventional studies can be faster performed, also as a network that can be contacted by pharmaceutical companies.

**In person meetings scheduled for EAU congress, ECCMID, AUA and KAUTII postponed due to COVID-19**

Last updated: February 16th-2022